ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2018
Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 2 syntheses or guidelines pooled it, 55 citations in OpenAlex.
- 18F-fluoroestradiol positron emission tomography in patients with breast cancer: a systematic review and meta-analysis.Revista da Associacao Medica Brasileira (1992) · 2023Pooled it
- Pooled it
- Clinical impact ofEuropean journal of nuclear medicine and molecular imaging · 2026Article
- Novel 4D radiomics applied to dynamic FES PET images to improve prediction of breast cancer response to ER-targeted therapy.European journal of nuclear medicine and molecular imaging · 2026Article
- Orbital metastasis from breast carcinoma: structured literature review and report of four cases.Frontiers in ophthalmology · 2026Article
- Predictive and prognostic value ofEuropean journal of nuclear medicine and molecular imaging · 2025Article
- [EJNMMI research · 2025Article
- Dynamic whole-body [EJNMMI research · 2024Article
- Article
- Nuclear Receptor Imaging In Vivo-Clinical and Research Advances.Journal of the Endocrine Society · 2023Review
- ER status conversion and subsequent treatment: an assessment of negative ER expression detected by 18F-FES PET in metastatic breast cancer patients with ER-positive primary tumors.Therapeutic advances in medical oncology · 2023Article
- Imaging of Bone Metastases in Breast Cancer.Seminars in nuclear medicine · 2022Review
- Review
- Review
- Head-to-Head Comparison betweenJournal of clinical medicine · 2022Review
- Analyzing the Estrogen Receptor Status of Liver Metastases with [Diagnostics (Basel, Switzerland) · 2021Article
- Heterogeneity in Signaling Pathway Activity within Primary and between Primary and Metastatic Breast Cancer.Cancers · 2021Article
- Head-to-Head Evaluation ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2021Article
- The quest for improving the management of breast cancer by functional imaging: The discovery and development of 16α-[Nuclear medicine and biology · 2021Review
- Positron Emission Tomography-Based Response to Target and Immunotherapies in Oncology.Medicina (Kaunas, Lithuania) · 2020Review
Corrections and comments
- Commented on by
Authors and funding
9 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Heterogeneity of estrogen receptor (ER) expression in breast cancer is recognized. However, knowledge about varying expression across metastases and surrounding normal tissue in patients is scarce. We therefore analyzed 16α-
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.